Aurinia Pharmaceuticals
AUPH
AUPH
114 hedge funds and large institutions have $991M invested in Aurinia Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+42
Holders Change %
+58.33%
% of All Funds
2.25%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
%
% of All Funds
0.12%
New
51
Increased
28
Reduced
19
Closed
8
Calls
$89.1M
Puts
$39.3M
Net Calls
+$49.8M
Net Calls Change
+$49.3M
Top Buyers
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$47.5M |
| 2 |
2
Goldman Sachs
New York
|
$12.6M |
| 3 |
PC
3
Polar Capital
London,
United Kingdom
|
$0 |
| 4 |
4
Ameriprise
Minneapolis,
Minnesota
|
$2.98M |
| 5 |
5
D.E. Shaw & Co
New York
|
$0 |
